Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03631953
Title Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas (ALTREM)
Acronym ALTREM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Assistance Publique Hopitaux De Marseille
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.